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Abstract : Background. Sometimes intraoperative urethral injury occurs in Transanal total mesorectal excision 
(TaTME). The aim of this study is to investigate the usefulness of indocyanine green (ICG) fluorescent catheter 
system for avoiding intraoperative urethral injury in TaTME in experimental model. Methods. A urethral cathe-
ter was filled with the mixture of albumin and ICG and raw hams were applied in layers as the surrogate model 
of rectourethral muscle. The detectability of ICG fluorescence in this catheter was investigated by using laparo-
scope-type fluorescence camera system. Results. Fluorescence was detected when ICG was mixed with albumin 
or peripheral blood. ICG fluorescence could be detected within 4 mm depth of layered raw hams as the surrogate 
model. Quantitative analysis of the picture detected that ICG fluorescence plateaued in lower concentration 
than that of serum. Conclusion. ICG fluorescent catheter system may be useful for avoiding intraoperative ure-
thral injury in TaTME. J. Med. Invest. 67 : 285-288, August, 2020
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INTRODUCTION
 
Transanal total mesorectal excision (TaTME) is a new sur-
gical procedure for curative treatment of lower rectal cancer (1). 
This “down-to-up” procedure is more effective for dissection of 
the intrapelvic part in cases with obesity, narrow pelvis cavity, 
and bulky tumor compared with the conventional laparoscopic 
transabdominal approach (2). According to a systematic review, 
TaTME enables dissection of the rectal wall with adequate 
circumferential resection margin (CRM) and distal margin (3).
TaTME requires a transanal incision between the external 
and internal sphincter muscles and dissection of the smooth 
muscle layer. During dissection of the anterior rectal wall, the 
rectourethral muscle is incised. However, there is no obvious 
anatomical landmark, and the anterior rectal wall is close to the 
urethra (4). Intraoperative urethral injury was reported to occur 
in 2%-6% of cases (5-7). If the urethral wall can be detected more 
easily, the surgery could become safer. Anatomical navigation of 
the urethra is necessary to avoid intraoperative urethral injury.
Indocyanine green (ICG) fluorescence is used for anatomical 
navigation in several procedures, including mastectomy (8), cor-
onary bypass graft (9), and hepatectomy (10). Dapris et al. (11). 
reported that ICG direct injection and fluorescence were useful 
for understanding the tumor dissection layer in TaTME. Howev-
er, there are no reports on the usefulness of ICG fluorescence as 
a navigational tool to avoid intraoperative urethral injury. ICG 
fluorescence may contribute to easier location of the urethra. The 
aim of this study was to investigate the usefulness of an ICG 
fluorescence catheter system for avoiding intraoperative urethral 
injury in TaTME using an experimental model.
MATERIALS AND METHODS
Validation of materials with detectable fluorescence
ICG fluorescence detectability in materials was investigated 
in a preliminary experiment. ICG (Daiichi-Sankyo, Japan) was 
prepared by dissolution in distilled water to a concentration of 
2.5 mg / mL. Fluorescence of ICG in a 25% solution of human 
serum albumin (Nihon Pharmaceutical, Japan), peripheral 
human blood, urine from a healthy volunteer, or catheter jelly 
(Aspen, Japan) was evaluated using an Image 1 SPIES fluores-
cence camera system (Karl-Storz, Germany) at a distance of 4 
cm. 
Measurement of detectable thickness for ICG fluorescence
The detectability of ICG fluorescence was investigated. ICG 
(3 mL) was mixed with 25% albumin (7 mL) and placed in a 14 
French silicon Foley catheter (Bard, USA). Raw ham layers as a 
surrogate model for the rectourethral muscle were laid over the 
Foley catheter. Fluorescence was evaluated using the Image 1 
SPIES fluorescence camera system at a distance of 4 cm and an 
angle of 45° (Figure 1).
Correlation between albumin concentration and fluorescence 
intensity 
Fluorescence of ICG in 25% albumin repeatedly diluted by 
two-fold was observed using the Image 1 SPIES fluorescence 
camera system as described above. Images of individual samples 
were taken by capturing a movie for analysis of fluorescence 
intensity. Fluorescence intensity in the captured images was 
plotted using Image J version 1.51j8 software (NIH, USA) as 
described previously (12).
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Fluorescence evaluation
All fluorescence was evaluated in terms of fluorescence detec-
tion (yes / no) and fluorescence intensity (strong / weak) five times 
by three expert surgeons.
Statistical analysis
Statistical analyses were performed using SPSS statistics 
version 24 software (IBM, USA). All data were analyzed by the 
chi-square test. Values of p < 0.05 were considered to indicate 
significant differences.
RESULTS
ICG mixed with albumin or peripheral blood generates strong 
fluorescence
Fluorescence of ICG was investigated in mixtures with differ-
ent materials. Four materials, peripheral blood, human serum 
albumin, human urine, and catheter jelly, were compared on 
the assumption that these materials are in clinical use during 
surgery. As a result, ICG fluorescence was detected in albumin 
or peripheral blood (fluorescence : yes 3 / no 0 ; intensity : strong 
3 / weak 0). Fluorescence was not detected in urine and weakly 
detected in catheter jelly (Figure 2).
Figure 1.　Experimental design of the surrogate model used in the study of detectable depth of ICG fluorescence.
Figure 2.　Fluorescence of mixtures of ICG and four materials, namely urine, peripheral blood, catheter jelly, and 
human serum albumin. Fluorescence of ICG was detected in mixtures with peripheral blood or albumin. 
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ICG fluorescence can be detected up to 4-mm depth in muscle
The maximum depth in muscles for detection of ICG fluores-
cence was measured as the detectability. For this experiment, 
the surrogate model was used (Figure 1). As the thickness of the 
raw ham layers increased, the fluorescence detection became 
weaker. At 4-mm thickness, the fluorescence was weak but 
was still detected (fluorescence : yes 3 / no 0 ; intensity : strong 
0 / weak 3). Fluorescence was not observed at 5-mm thickness 
(Figure 3). 
Low concentration of albumin can generate fluorescence with ICG
In clinical use, ICG is retrogradely injected and diluted by 
mixing with urine. The ICG solution was diluted and validated 
for detection of adequate fluorescence. As the albumin prepara-
tion concentration decreased, the detected fluorescence became 
weaker. The ICG fluorescence intensity plateaued at 0.78% albu-
min (1 : 25 dilution) (Figure 4).
 
DISCUSSION
The results of the present study suggest that the ICG fluores-
cence catheter system may enable clinicians to become aware of 
whether or not the dissection line is close to the urethral wall.
In the conventional laparoscopic procedure, it is difficult to 
perform the resection with an adequate operative field in cases 
with obesity, narrow pelvis, or bulky tumor. As a result, posi-
tive CRM cases occur at 10%-16% (13, 14). Inadequate surgical 
CRM and distal margin bring about earlier recurrence (15). As 
an alternative, TaTME was reported to have shorter operation 
time, fewer postoperative complications, lower conversion rate, 
and more adequate resection margin, including CRM and distal 
margin, compared with the laparoscopic procedure in terms of 
short-term outcomes in systematic reviews (2, 3). 
In TaTME, urethral injury was reported to occur in 2%-6% 
of cases (5-7). To avoid urethral injury, strategies involving ac-
curate anatomical navigation have been investigated. Atallah 
et al. (16) suggested real-time navigation by preoperative pelvic 
magnetic resonance imaging (MRI). However, this was not 
true real-time navigation, and the deviation was ± 3.69 mm in 
fiducial placement. In our experiment, the ICG catheter system 
could be used for real-time navigation with detectability up to 
4-mm depth, and may be superior to MRI navigation.
ICG excites green fluorescence from near-infrared light of 
wavelength > 790 nm. After injection into a peripheral vein, 
almost 95% of ICG molecules bind to serum albumin (17). Be-
cause the urine of healthy people does not contain albumin, it 
is necessary to perform retrograde intraurethral injection of 
an ICG-albumin mixture to detect urethral fluorescence. The 
ICG fluorescence catheter system is a simple and non-invasive 
technique, and may become a useful and safe option. A recent 
cadaveric study confirmed that retrograde direct intraurethral 
ICG injection is useful for detection of the urethra (18). The pres-
ent report supports the notion that retrograde intraurethral ICG 
injection enables detection of the urethra.
The present results confirm that a low concentration of albu-
min can allow adequate detection of ICG fluorescence through 
a silicon catheter. In other words, adequate fluorescence can 
even be observed when the ICG-albumin mixture is mixed with 
urine and diluted. Our experiments proved that adequate fluo-
rescence was detected after retrograde intraurethral injection 
with a catheter system. However, the study did not contain in 
vivo investigations such as animal models and clinical studies. 
Figure 4.　Validation of ICG fluorescence. ICG fluorescence plateaued in 0.78% human albumin.
Figure 3.　ICG fluorescence was detected up to 4-mm depth, but not 
at 5-mm depth, in raw ham layers. Images of ICG fluorescence in a 
mixture with albumin at depths of 0-5 mm in raw ham layers.
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To further clarify the feasibility and usefulness of the ICG fluo-
rescence catheter system, we plan to perform an in vivo study or 
clinical trial.
In conclusion, we have provided evidence that the ICG fluores-
cence catheter system may be useful for avoiding intraoperative 
urethral injury in TaTME. If the urethra can be detected more 
easily in the operative view, TaTME may become a safer treat-
ment procedure for mid and low rectal cancer.
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